Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrowth improved, but quality of life did not.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Multiple treatment comparison meta-analyses help doctors make better decisions by comparing different interventions.

Aminexil clinical 5 effectively reduces hair loss and is well-tolerated.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

Frailer men have a higher risk of worsening prostate problems and serious health events needing hospital care.

The safety of the hair loss drug finasteride is unclear due to inadequate reporting in clinical trials.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

All HPV vaccine studies should be registered and published to reduce reporting bias.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Dual wavelength LED caps can safely increase hair density in androgenetic alopecia.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.